HLA-Cw6基因对生物制剂治疗银屑病疗效影响的Meta分析
2019, Vol.35(6): 321326 https://doi.org/10.12144/zgmfskin201906321
2019, Vol.35(6): 327329 https://doi.org/10.12144/zgmfskin201906327
2019, Vol.35(6): 330333 https://doi.org/10.12144/zgmfskin201906330
2019, Vol.35(6): 334337 https://doi.org/10.12144/zgmfskin201906334
2019, Vol.35(6): 338341 https://doi.org/10.12144/zgmfskin201906338
2019, Vol.35(6): 342345 https://doi.org/10.12144/zgmfskin201906342
2019, Vol.35(6): 346348 https://doi.org/10.12144/zgmfskin201906346
2019, Vol.35(6): 349351 https://doi.org/10.12144/zgmfskin201906349
2019, Vol.35(6): 352353 https://doi.org/10.12144/zgmfskin201906352
2019, Vol.35(6): 354355 https://doi.org/10.12144/zgmfskin201906354
界限类偏瘤型麻风伴II型麻风反应一例
2019, Vol.35(6): 356357 https://doi.org/10.12144/zgmfskin201906356
2019, Vol.35(6): 358359 https://doi.org/10.12144/zgmfskin201906358
2019, Vol.35(6): 360360 https://doi.org/10.12144/zgmfskin201906360
2019, Vol.35(6): 361362 https://doi.org/10.12144/zgmfskin201906361
2019, Vol.35(6): 362363 https://doi.org/10.12144/zgmfskin201906362
2019, Vol.35(6): 364364 https://doi.org/10.12144/zgmfskin201906364
2019, Vol.35(6): 365367 https://doi.org/10.12144/zgmfskin201906365
2019, Vol.35(6): 367368 https://doi.org/10.12144/zgmfskin201906367
2019, Vol.35(6): 369371 https://doi.org/10.12144/zgmfskin201906369
2019, Vol.35(6): 372374 https://doi.org/10.12144/zgmfskin201906372
2019, Vol.35(6): 375379 https://doi.org/10.12144/zgmfskin201906375
2019, Vol.35(6): 380384 https://doi.org/10.12144/zgmfskin201906380